LMAT Long Call Strategy

LMAT (LeMaitre Vascular, Inc.), in the Healthcare sector, (Medical - Instruments & Supplies industry), listed on NASDAQ.

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors.

LMAT (LeMaitre Vascular, Inc.) trades in the Healthcare sector, specifically Medical - Instruments & Supplies, with a market capitalization of approximately $2.24B, a trailing P/E of 35.87, a beta of 0.60 versus the broader market, a 52-week range of 78.35-118.01, average daily share volume of 252K, a public-listing history dating back to 2006, approximately 651 full-time employees. These structural characteristics shape how LMAT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.60 indicates LMAT has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. The trailing P/E of 35.87 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple. LMAT pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.

What is a long call on LMAT?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current LMAT snapshot

As of May 14, 2026, spot at $99.27, ATM IV 30.20%, IV rank 2.32%, expected move 8.66%. The long call on LMAT below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this long call structure on LMAT specifically: LMAT IV at 30.20% is on the cheap side of its 1-year range, which favors premium-buying structures like a LMAT long call, with a market-implied 1-standard-deviation move of approximately 8.66% (roughly $8.59 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated LMAT expiries trade a higher absolute premium for lower per-day decay. Position sizing on LMAT should anchor to the underlying notional of $99.27 per share and to the trader's directional view on LMAT stock.

LMAT long call setup

The LMAT long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With LMAT near $99.27, the first option leg uses a $100.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed LMAT chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 LMAT shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$100.00$2.70

LMAT long call risk and reward

Net Premium / Debit
-$270.00
Max Profit (per contract)
Unbounded
Max Loss (per contract)
-$270.00
Breakeven(s)
$102.70
Risk / Reward Ratio
Unbounded

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

LMAT long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on LMAT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price% From SpotP&L at Expiration
$0.01-100.0%-$270.00
$21.96-77.9%-$270.00
$43.91-55.8%-$270.00
$65.85-33.7%-$270.00
$87.80-11.6%-$270.00
$109.75+10.6%+$705.02
$131.70+32.7%+$2,899.82
$153.65+54.8%+$5,094.63
$175.59+76.9%+$7,289.43
$197.54+99.0%+$9,484.24

When traders use long call on LMAT

Long calls on LMAT express a bullish thesis with defined risk; traders use them ahead of LMAT catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

LMAT thesis for this long call

The market-implied 1-standard-deviation range for LMAT extends from approximately $90.68 on the downside to $107.86 on the upside. A LMAT long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current LMAT IV rank near 2.32% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on LMAT at 30.20%. As a Healthcare name, LMAT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to LMAT-specific events.

LMAT long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. LMAT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move LMAT alongside the broader basket even when LMAT-specific fundamentals are unchanged. Long-premium structures like a long call on LMAT are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current LMAT chain quotes before placing a trade.

Frequently asked questions

What is a long call on LMAT?
A long call on LMAT is the long call strategy applied to LMAT (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With LMAT stock trading near $99.27, the strikes shown on this page are snapped to the nearest listed LMAT chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are LMAT long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the LMAT long call priced from the end-of-day chain at a 30-day expiry (ATM IV 30.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$270.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a LMAT long call?
The breakeven for the LMAT long call priced on this page is roughly $102.70 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current LMAT market-implied 1-standard-deviation expected move is approximately 8.66%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on LMAT?
Long calls on LMAT express a bullish thesis with defined risk; traders use them ahead of LMAT catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current LMAT implied volatility affect this long call?
LMAT ATM IV is at 30.20% with IV rank near 2.32%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related LMAT analysis